In the latest episode of the Next Regeneration podcast, hosts Anina and Elena talk to Nikos Donos, who shares his more than 20 years of experience using biologics for tissue regeneration and discusses the potential and limitations of different biologic agents. Much of his research has contributed to a better understanding of how different biological factors can enhance specific pathways in the healing cascade, and therefore the importance of using them in a biologically oriented way to maximise their efficacy.

In this interview, Donos reflects on how patient selection will become increasingly important. In this respect, biologics that specifically enhance the resolution of inflammation may likely be beneficial in patients with diseases with inflammatory pathogenesis, such as diabetes. Tune in now to discover expert insights on leveraging biologics for optimal tissue regeneration.